Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Sorrento Announces Drilling Contract & Receives Permit to Drill Bottom Brook Project (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News ABVC Biopharma Inc ABVC

Healthcare Biotechnology
ABVC BioPharma, Inc., a clinical-stage biopharmaceutical company, develops drugs and medical devices to fulfill unmet medical needs in the United States. The company is developing ABV-1501, which is in Phase II clinical trials as a combination therapy for triple negative breast cancer; ABV-1504, which has completed Phase II clinical trials for depressive disorders; ABV-1505, which is in Phase... see more

Current News (NDAQ:ABVC)

ABVC BioPharma Highlights Safety Profile of Its Plant-Based ADHD Candidate Amid Growing Concerns About Psychiatric Polypharmacy in the United States

TheNewsWire December 2, 2025

ABVC BioPharma Highlights Strengthened Operations at BioKey's 28,176-sq.-ft. Silicon Valley Facility, Featuring U.S.-Based Multi-Product Capabilities Including Functional Foods, and Expansion Outlook Supporting Up to [1,000] Jobs by 2030

TheNewsWire November 26, 2025

ABVC Receives US$250,000 From ForSeeCon; Vitargus(R) Total Licensing Fee up to US$33.5 Million; US$816,000 Already Received

TheNewsWire November 21, 2025

ABVC BioPharma Receives US$240,000 Licensing Payment From OncoX BioPharma; Total Licensing Payments Reach Approximately US$2.53 Million

TheNewsWire November 18, 2025

ABVC BioPharma Reports 230% YoY Licensing Revenue Growth and 181% Asset Expansion in Q3 2025

TheNewsWire November 3, 2025

ABVC BioPharma Receives Additional US$100,000 Licensing Payment from OncoX BioPharma, Bringing Total Payments to US$695,950

TheNewsWire October 31, 2025

ABVC BioPharma Highlighted by U.S. Financial Media as One of the Best Biotech Investments; Q3 Licensing Revenue Reaches $1.27 Million, With Clear Clinical Progress Across CNS and Oncology

TheNewsWire October 17, 2025

ABVC BioPharma Has Received a Cumulative Total of US$566,000 Under ForSeeCon Licensing Agreement Supporting GMP Facility in Hsinchu for Vitargus(R) Production

TheNewsWire October 8, 2025

ABVC BioPharma Reports US$1.03 Million in Total Licensing Revenues Collected in Q3 to Date, Highlighting High-Margin Business Model

TheNewsWire September 19, 2025
View More News ››

Opinion & Analysis (NDAQ:ABVC)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:ABVC)

ABVC BioPharma, Inc. (NASDAQ: ABVC): A Promising Biopharmace

http://beyondspx.com/2024/07/31/abvc-biopharma-inc-nasdaq-abvc-a-promising-biopharmaceutical-player-navigating-the-ophthalmology-cns-and...
MikeTester - August 2, 2024

ABVC.....Let the bleeding continue

Sheesh
Iseneschal - March 26, 2024

RE:ABVC.....Early a.m runner on NR

Reading what a few are saying about ABVC ....... every PR this company puts out is a deal with some company you can’t do any DD on
Iseneschal - March 26, 2024

ABVC.....Early a.m runner on NR

Volume & Price action No position.... $1.60
Iseneschal - March 26, 2024

ABVC... slow death

JMHO The NR talked of Big #'s.......Talk is cheap It's all B ............ S
Iseneschal - October 27, 2023

RE:RE:RE:ABVC.... All Chasers were laid out by the ST Whores

Well well well....Mr. Nib...the man with few words....always around a "train wreck" Explain yourself please....in English ; )
Iseneschal - October 27, 2023
View more Bullboard ››

PlasCred Circular Innovations Inc.

PlasCred Circular Innovations Inc.

PlasCred is building industrial-scale recycling infrastructure to convert mixed plastic waste into high-value hydrocarbon ...
View More »

Podcasts